AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Choudhry, A. E.
Right arrow Articles by Ratnam, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Choudhry, A. E.
Right arrow Articles by Ratnam, K.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, June 2003, p. 2051-2055, Vol. 47, No. 6
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.6.2051-2055.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Inhibitors of Pantothenate Kinase: Novel Antibiotics for Staphylococcal Infections

Anthony E. Choudhry,1 Tracy L. Mandichak,1,{dagger} John P. Broskey,1 Richard W. Egolf,1,{dagger} Cynthia Kinsland,2 Tadhg P. Begley,2 Mark A. Seefeld,1 Thomas W. Ku,1 James R. Brown,1* Magdalena Zalacain,1 and Kapila Ratnam1*

Microbial, Musculoskeletal and Proliferative Diseases and Bioinformatics, GlaxoSmithKline Pharmaceuticals, Collegeville Pennsylvania 19426,1 Department of Chemistry and Chemical Biology, Cornell University, Ithaca New York 148502

Received 22 November 2002/ Returned for modification 20 January 2003/ Accepted 28 February 2003

Pantothenate kinase (CoaA) catalyzes the first step of the coenzyme A biosynthetic pathway. Here we report the identification of the Staphylococcus aureus coaA gene and characterization of the enzyme. We have also identified a series of low-molecular-weight compounds which are effective inhibitors of S. aureus CoaA.


* Corresponding author. Mailing address: Microbial, Musculoskeletal and Proliferative Diseases and Bioinformatics, GlaxoSmithKline Pharmaceuticals, 1250 S. Collegeville Rd., Collegeville, PA 19426. Phone: (610) 917-6399. Fax: (610) 917-7901. E-mail for James R. Brown: james.r.brown{at}gsk.com. E-mail for Kapila Ratnam: kapila.2.ratnam{at}gsk.com.

{dagger} Present address: The Pennsylvania State University, Eberly College of Science, University Park, PA 16802-6004.


Antimicrobial Agents and Chemotherapy, June 2003, p. 2051-2055, Vol. 47, No. 6
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.6.2051-2055.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2003 by the American Society for Microbiology. All rights reserved.